Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MJX Asset Management is a specialized independent asset manager based in the United States that focuses on investing in leveraged finance assets and managing structured products such as collateralized loan obligations (CLOs). Founded in 2003 by Hans Christensen and Martin Davey, it currently manages over $15.7 billion across more than twenty CLO funds primarily invested in senior secured leveraged loans. The firm is wholly owned by its management team and does not operate within the life sciences/biotech/pharma/healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MJX Asset Management.